{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:24:31Z","timestamp":1760300671224,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071036","82000973"],"award-info":[{"award-number":["82071036","82000973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2019JJ50967","2017JJ3441"],"award-info":[{"award-number":["2019JJ50967","2017JJ3441"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Middle ear cholesteatoma is characterized by hyper-proliferation of keratinocytes. Circular RNA (circRNA) plays an essential role in the pathogenesis of many proliferative diseases. However, the role of circRNA in the etiopathogenesis of middle ear cholesteatoma is rarely investigated so far. We aimed to investigate the differential expression profiling of circRNAs between acquired middle ear cholesteatoma and normal skin, and to identify potential circRNAs contributing to the etiopathogenesis of middle ear cholesteatoma. Microarray analysis and functional prediction were performed to investigate the circRNA expression profiling between middle ear cholesteatoma and normal skin. Validation of differentially expressed circRNAs was conducted by qRT-PCR. Prediction of m<jats:sup>6<\/jats:sup>A modification was also carried out.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Microarray analysis displayed that totally 93 up-regulated and 85 down-regulated circRNAs were identified in middle ear cholesteatoma. Through validation, expressions of hsa_circRNA_104327 and hsa_circRNA_404655 were significantly higher, while hsa_circRNA_000319 was significantly down-regulated in cholesteatoma. GO classification, KEGG pathway, and ceRNA network analyses suggested that these differentially expressed circRNAs might play important roles in the etiopathogenesis of middle ear cholesteatoma. Prediction of m<jats:sup>6<\/jats:sup>A modification exhibited that hsa_circRNA_000319 possessed 4 m<jats:sup>6<\/jats:sup>A sites with very high confidence, and hsa_circRNA_404655 had 3 m<jats:sup>6<\/jats:sup>A sites with high confidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study revealed that these differentially expressed circRNAs might contribute to the etiopathogenesis of middle ear cholesteatoma. Further researches should be conducted to investigate the exact mechanism of these differentially expressed circRNAs in the etiopathogenesis of middle ear cholesteatoma. Targeting on these circRNAs may provide a new strategy for middle ear cholesteatoma therapy in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12938-021-00960-x","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T14:02:24Z","timestamp":1639836144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Shumin","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuanfang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-7664","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"3","key":"960_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12105-018-0915-5","volume":"12","author":"JT Castle","year":"2018","unstructured":"Castle JT. Cholesteatoma pearls: practical points and update. Head Neck Pathol. 2018;12(3):419\u201329.","journal-title":"Head Neck Pathol"},{"issue":"5","key":"960_CR2","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00405-016-4422-6","volume":"274","author":"S Xie","year":"2017","unstructured":"Xie S, Wang X, Ren J, Liu W. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol. 2017;274(5):2071\u20138.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"960_CR3","doi-asserted-by":"publisher","first-page":"d1088","DOI":"10.1136\/bmj.d1088","volume":"342","author":"MF Bhutta","year":"2011","unstructured":"Bhutta MF, Williamson IG, Sudhoff HH. Cholesteatoma. BMJ. 2011;342:d1088.","journal-title":"BMJ"},{"issue":"2","key":"960_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000301156","volume":"72","author":"ZG Zhang","year":"2010","unstructured":"Zhang ZG, Chen SJ, Sun W, Zheng YQ. Classification and surgical management of localized attic cholesteatoma: single-institution experience and follow-up. ORL. 2010;72(2):96\u2013100.","journal-title":"ORL"},{"issue":"5","key":"960_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453\u201361.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"960_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12938-021-00857-9","volume":"20","author":"LJ Galv\u00e3o-Lima","year":"2021","unstructured":"Galv\u00e3o-Lima LJ, Morais AHF, Valentim RAM, Barreto EJSS. miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. Biomed Eng Online. 2021;20(1):21.","journal-title":"Biomed Eng Online"},{"issue":"4","key":"960_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","volume":"157","author":"R Dai","year":"2011","unstructured":"Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res. 2011;157(4):163\u201379.","journal-title":"Transl Res"},{"issue":"7441","key":"960_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384\u20138.","journal-title":"Nature"},{"issue":"18","key":"960_CR9","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-13-1568","volume":"73","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 2013;73(18):5609\u201312.","journal-title":"Cancer Res"},{"issue":"1","key":"960_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12920-019-0616-2","volume":"12","author":"LI Moldovan","year":"2019","unstructured":"Moldovan LI, Hansen TB, Ven\u00f8 MT, Okholm TLH, Andersen TL, Hager H, et al. High-throughput RNA sequencing from paired lesional- and non-lesional skin reveals major alterations in the psoriasis circRNAome. BMC Med Genomics. 2019;12(1):174.","journal-title":"BMC Med Genomics"},{"issue":"2","key":"960_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2017.05.164","volume":"490","author":"RY Dang","year":"2017","unstructured":"Dang RY, Liu FL, Li Y. Circular RNA hsa_circ_0010729 regulates vascular endothelial cell proliferation and apoptosis by targeting the miR-186\/HIF-1\u03b1 axis. Biochem Biophys Res Commun. 2017;490(2):104\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"960_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.omtn.2019.10.019","volume":"18","author":"X Wang","year":"2019","unstructured":"Wang X, Cao X, Dong D, Shen X, Cheng J, Jiang R, et al. Circular RNA TTN Acts As a miR-432 sponge to facilitate proliferation and differentiation of myoblasts via the IGF2\/PI3K\/AKT signaling pathway. Mol Ther Nucleic Acids. 2019;18:966\u201380.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"960_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.21053\/ceo.2016.01263","volume":"10","author":"MA Hamed","year":"2017","unstructured":"Hamed MA, Nakata S, Shiogama K, Suzuki K, Sayed RH, Nishimura Y, et al. Cytokeratin 13, cytokeratin 17, and Ki-67 expression in human acquired cholesteatoma and their correlation with its destructive capacity. Clin Exp Otorhinolaryngol. 2017;10(3):213\u201320.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"960_CR14","first-page":"651207","volume":"2013","author":"W Liu","year":"2013","unstructured":"Liu W, Ren H, Ren J, Yin T, Hu B, Xie S, et al. The role of EGFR\/PI3K\/Akt\/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Mediators Inflamm. 2013;2013:651207.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"960_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00405-013-2403-6","volume":"271","author":"W Liu","year":"2014","unstructured":"Liu W, Yin T, Ren J, Li L, Xiao Z, Chen X, et al. Activation of the EGFR\/Akt\/NF-\u03baB\/cyclinD1 survival signaling pathway in human cholesteatoma epithelium. Eur Arch Otorhinolaryngol. 2014;271(2):265\u201373.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"13","key":"960_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.7150\/ijms.26329","volume":"15","author":"S Xie","year":"2018","unstructured":"Xie S, Liu X, Pan Z, Chen X, Peng A, Yin T, et al. Microarray analysis of differentially-expressed MicroRNAs in acquired middle ear cholesteatoma. Int J Med Sci. 2018;15(13):1547\u201354.","journal-title":"Int J Med Sci"},{"issue":"2","key":"960_CR17","doi-asserted-by":"publisher","first-page":"e12720","DOI":"10.1111\/cpr.12720","volume":"53","author":"G Pan","year":"2020","unstructured":"Pan G, Mao A, Liu J, Lu J, Ding J, Liu W. Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326\/TFF1 signalling. Cell Prolif. 2020;53(2):e12720.","journal-title":"Cell Prolif"},{"issue":"6","key":"960_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214\u201327.","journal-title":"J Hepatol"},{"issue":"8","key":"960_CR19","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.18632\/oncotarget.3469","volume":"6","author":"F Li","year":"2015","unstructured":"Li F, Zhang L, Li W, Deng J, Zheng J, An M, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt\/\u03b2-catenin pathway. Oncotarget. 2015;6(8):6001\u201313.","journal-title":"Oncotarget"},{"issue":"4","key":"960_CR20","first-page":"1234","volume":"43","author":"J Gao","year":"2020","unstructured":"Gao J, Tang Q, Xue R, Zhu X, Wang S, Zhang Y, et al. Comprehensive circular RNA expression profiling with associated ceRNA network reveals their therapeutic potential in cholesteatoma. Oncol Rep. 2020;43(4):1234\u201344.","journal-title":"Oncol Rep"},{"issue":"12","key":"960_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/00016489.2016.1202447","volume":"136","author":"X Chen","year":"2016","unstructured":"Chen X, Li X, Qin Z. MicroRNA-21 promotes the proliferation and invasion of cholesteatoma keratinocytes.\u00a0Acta Otolaryngol. 2016;136(12):1261\u20136.","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"960_CR22","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3892\/mmr.2014.2971","volume":"11","author":"W Zhang","year":"2015","unstructured":"Zhang W, Chen X, Qin Z. MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes.\u00a0Mol Med Rep. 2015;11(3):2097\u2013103.","journal-title":"Mol Med Rep"},{"issue":"1","key":"960_CR23","doi-asserted-by":"publisher","first-page":"9169","DOI":"10.1038\/s41598-019-42364-x","volume":"9","author":"T An","year":"2019","unstructured":"An T, Fan T, Zhang XQ, Liu YF, Huang J, Liang C, et al. Comparison of Alterations in miRNA Expression in Matched Tissue and Blood Samples during Spinal Cord Glioma Progression. Sci Rep. 2019;9(1):9169.","journal-title":"Sci Rep"},{"issue":"1","key":"960_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-017-1275-8","volume":"15","author":"Y Shi","year":"2017","unstructured":"Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, et al. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J Transl Med. 2017;15(1):176.","journal-title":"J Transl Med"},{"issue":"10","key":"960_CR25","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1002\/jcb.29666","volume":"121","author":"J Xu","year":"2020","unstructured":"Xu J, Shi J, Tang W, Jiang P, Guo M, Zhang B, et al. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK\/p38 signaling pathway in breast cancer. J Cell Biochem. 2020;121(10):4142\u201353.","journal-title":"J Cell Biochem"},{"issue":"27","key":"960_CR26","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.7150\/jca.36430","volume":"10","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen H, et al. RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. J Cancer. 2019;10(27):6837\u201347.","journal-title":"J Cancer"},{"issue":"11","key":"960_CR27","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.18632\/oncotarget.3369","volume":"6","author":"S Bhatia","year":"2015","unstructured":"Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, et al. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget. 2015;6(11):8929\u201346.","journal-title":"Oncotarget"},{"issue":"10","key":"960_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/15384101.2016.1166319","volume":"15","author":"R Boudra","year":"2016","unstructured":"Boudra R, Lagrafeuille R, Lours-Calet C, de Joussineau C, Loubeau-Legros G, Chaveroux C, et al. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation. Cell Cycle. 2016;15(10):1352\u201362.","journal-title":"Cell Cycle"},{"issue":"64","key":"960_CR29","doi-asserted-by":"publisher","first-page":"107932","DOI":"10.18632\/oncotarget.22429","volume":"8","author":"K Sun","year":"2017","unstructured":"Sun K, Wang S, He J, Xie Y, He Y, Wang Z, et al. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K\/AKT pathway. Oncotarget. 2017;8(64):107932\u201346.","journal-title":"Oncotarget"},{"issue":"8","key":"960_CR30","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1097\/MAO.0000000000002328","volume":"40","author":"M Takahashi","year":"2019","unstructured":"Takahashi M, Yamamoto-Fukuda T, Akiyama N, Motegi M, Yamamoto K, Tanaka Y, et al. Partial epithelial-mesenchymal transition was observed under p63 expression in acquired middle ear cholesteatoma and congenital cholesteatoma. Otol Neurotol. 2019;40(8):e803\u201311.","journal-title":"Otol Neurotol"},{"issue":"2","key":"960_CR31","first-page":"206","volume":"9","author":"W Liu","year":"2011","unstructured":"Liu W, Yin T, Ren J, Wang Y, Shen X, Li L, et al. Expression of PTEN, P-Akt and NF-\u03baB in middle ear cholesteatoma epithelium and its significance. Chinese J Otol. 2011;9(2):206\u201311.","journal-title":"Chinese J Otol"},{"issue":"10","key":"960_CR32","doi-asserted-by":"publisher","first-page":"e993","DOI":"10.1097\/MAO.0000000000002404","volume":"40","author":"Q Li","year":"2019","unstructured":"Li Q, Ao Y, Yu Q, Zhou S. Role of autophagy in acquired cholesteatoma. Otol Neurotol. 2019;40(10):e993\u20138.","journal-title":"Otol Neurotol"},{"issue":"7","key":"960_CR33","doi-asserted-by":"publisher","first-page":"e881","DOI":"10.1097\/MAO.0000000000002690","volume":"41","author":"KY Ho","year":"2020","unstructured":"Ho KY, Huang CJ, Hung CC, Wu YR, Chiu CC, Chien CY, et al. Autophagy is deficient and may be negatively regulated by SERPINB3 in middle ear cholesteatoma. Otol Neurotol. 2020;41(7):e881\u20138.","journal-title":"Otol Neurotol"},{"issue":"7","key":"960_CR34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/00005537-200307000-00018","volume":"113","author":"O Adunka","year":"2003","unstructured":"Adunka O, Gstoettner W, Knecht R, Kierner AC. Expression of hypoxia inducible factor 1 alpha and Von Hippel Lindau protein in human middle ear cholesteatoma. Laryngoscope. 2003;113(7):1210\u20135.","journal-title":"Laryngoscope"},{"issue":"5","key":"960_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y, et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017;27(5):626\u201341.","journal-title":"Cell Res"},{"issue":"3","key":"960_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.molcel.2019.02.034","volume":"74","author":"OH Park","year":"2019","unstructured":"Park OH, Ha H, Lee Y, Boo SH, Kwon DH, Song HK, et al. Endoribonucleolytic cleavage of m6A-containing RNAs by RNase P\/MRP complex. Mol Cell. 2019;74(3):494-507.e8.","journal-title":"Mol Cell"},{"issue":"1","key":"960_CR37","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","volume":"10","author":"RX Chen","year":"2019","unstructured":"Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, et al. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10(1):4695.","journal-title":"Nat Commun"},{"issue":"1","key":"960_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","volume":"76","author":"YG Chen","year":"2019","unstructured":"Chen YG, Chen R, Ahmad S, Verma R, Kasturi SP, Amaya L, et al. N6-methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76(1):96-109.e9.","journal-title":"Mol Cell"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-021-00960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-021-00960-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-021-00960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T14:03:20Z","timestamp":1639836200000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-021-00960-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1186\/s12938-021-00960-x","relation":{},"ISSN":["1475-925X"],"issn-type":[{"type":"electronic","value":"1475-925X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study procedure was approved by the Ethics Committee of The Second Xiangya Hospital of Central South University, and written informed consent was acquired from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}